Sign in

CIK 0000882095

  • Large accelerated filer

GILEAD SCIENCES, INC.

Sign in to watch
Ticker
GILD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943047598
Phone
+1 650-574-3000
Business address
333 LAKESIDE DR, FOSTER CITY, CA, 94404
Former names
GILEAD SCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$36,996,096
in 12 filings, $37.0M under 10b5-1 plans

Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-10 O'Day Daniel Patrick Chairman & CEO Option exercise +10,800 389,783
2023-03-10 O'Day Daniel Patrick Chairman & CEO Shares withheld for taxes −14,017 $79.50 $1.1M 375,766
2023-03-10 O'Day Daniel Patrick Chairman & CEO Option exercise · Restricted Stock Unit −19,488 96,563
2023-03-10 O'Day Daniel Patrick Chairman & CEO Option exercise · Restricted Stock Unit −10,800 85,763
2023-03-10 O'Day Daniel Patrick Chairman & CEO Grant or award · Restricted Stock Unit +47,170 132,933
2023-03-10 O'Day Daniel Patrick Chairman & CEO Grant or award · Non-qualified Stock Option (Right to Buy) +215,095 215,095
2023-03-10 Parsey Merdad Chief Medical Officer Option exercise +3,455 73,585
2023-03-10 Parsey Merdad Chief Medical Officer Option exercise +7,999 81,584
2023-03-10 Parsey Merdad Chief Medical Officer Shares withheld for taxes −5,328 $79.50 $424K 76,256
2023-03-10 Parsey Merdad Chief Medical Officer Option exercise · Restricted Stock Unit −3,455 40,646
2023-03-10 Parsey Merdad Chief Medical Officer Option exercise · Restricted Stock Unit −7,999 32,647
2023-03-10 Parsey Merdad Chief Medical Officer Grant or award · Restricted Stock Unit +16,665 49,312
2023-03-10 Parsey Merdad Chief Medical Officer Grant or award · Non-qualified Stock Option (Right to Buy) +76,000 76,000
2023-03-10 Patterson Sandra SVP, Controllership Option exercise +1,601 25,693
2023-03-10 Patterson Sandra SVP, Controllership Option exercise +1,320 27,013
2023-03-10 Patterson Sandra SVP, Controllership Shares withheld for taxes −801 $79.50 $64K 26,212
2023-03-10 Patterson Sandra SVP, Controllership Option exercise · Restricted Stock Unit −1,601 17,748
2023-03-10 Patterson Sandra SVP, Controllership Option exercise · Restricted Stock Unit −1,320 16,428
2023-03-10 Patterson Sandra SVP, Controllership Grant or award · Restricted Stock Unit +6,130 22,558
2023-03-10 Patterson Sandra SVP, Controllership Grant or award · Non-qualified Stock Option (Right to Buy) +10,405 10,405

Page 36 of 43 · 851 trades